Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Fl 23
Philadelphia, PA 19104Phone+1 215-615-5858Fax+1 215-349-8144
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
- Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1985 - 1986
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1980 - 1982
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- PA State Medical License 2001 - 2024
- VA State Medical License 1994 - 2002
- MD State Medical License 1986 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Philadelphia Magazine Castle Connolly, 2005-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) Start of enrollment: 2007 Dec 14
- Evaluation of KX2-391 in Patients With Advanced Malignancies Start of enrollment: 2007 Nov 01
- Safety Study of MGA271 in Refractory Cancer Start of enrollment: 2011 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 3568 citationsRadiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckJames A. Bonner, Paul M. Harari, Jordi Giralt, Nozar Azarnia, Dong M. Shin
The New England Journal of Medicine. 2006-02-09 - 68 citationsCisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.Joshua Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, Susan E. Bates, Tito Fojo
Journal of the National Cancer Institute. 2019-05-01 - 568 citationsT-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Acro...Patrick A. Ott, Yung-Jue Bang, Sarina Anne Piha-Paul, Albiruni Ryan Abdul Razak, Jaafar Bennouna
Journal of Clinical Oncology. 2019-02-01
Journal Articles
- Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus–Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, Karthik Rajasekaran, Ara A Chalian, Christopher H Rassekh, Roger B Cohen, Joshua Bauml, Gregory S Weinstein, Robert M Brody, JAMA Otolaryngology–Head & Neck Surgery
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
- Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerGregory S Weinstein, Charu Aggarwal, Roger B Cohen, Joshua Bauml, Alexander Lin, Clinical Cancer Research
Press Mentions
- Drs. Roger B. Cohen, Lee M. Ellis and John L. Marshall Join Actuate Therapeutics’ Scientific Advisory BoardOctober 18th, 2022
- Right to Try Fails to Show ‘Edge’ vs. Expanded Access Pathway Among Community OncologistsAugust 4th, 2021
- Heat Biologics to Showcase Favorable Survival Data of HS-110 in Previously Treated Non-Small Cell Lung Cancer Patients at 2021 American Society of Clinical Oncology Annual MeetingJune 4th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: